Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C (Q37149463)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1 reference

1 reference

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Paul J Clark

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Hans L Tillmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Keyur Patel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Andrew J Muir

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Cynthia D Guy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Josephine H Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Alexander Thompson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Stephen D Gardner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

John G McHutchison

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jeanette J McCarthy

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

14 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1195-1200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

IL28B and the control of hepatitis C virus infection

5 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Meta-regulation: microRNA regulation of glucose and lipid metabolism

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

The effect of interferon on the metabolism of LDLs

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Screening for IL28B gene variants identifies predictors of hepatitis C therapy success

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763913

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group

3 September 2018

1 reference

12 December 2020

Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma lipases

1 reference

12 December 2020

Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C

1 reference

12 December 2020

Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C

1 reference

12 December 2020

10.1016/J.JHEP.2011.03.015

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21703198%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference